News

At the end of 2025, the efforts of DLP and partners in conducting the C-FREE-1 study culminated in the acceptance for publication of a comprehensive article  in the peer-reviewed high-impact Bulletin of the World Health Organization (WHO) .   The open-access article disseminates information globally on the detailed design, results, and impact of the C-FREE model of community-based care for high-risk populations: 2,871 participants coming from as many as 50 provinces in Thaila

On 24 November 2025, the World Hepatitis Alliance (WHA) visited the C-FREE site, BMA New Step Clinic, Ladprao, Bangkok , in preparation for site visits to be organized during the World Hepatitis Summit (WHS), which will take place in Bangkok in April 2026. World Hepatitis Alliance (WHA) is an international non-governmental organisation best known for advocating and raising awareness for viral hepatitis elimination. The organisation represents 337 members from 102 countries

On September 30, 2025, representatives of the PDP Funders Group  visited the C-FREE-CSEA study site of Samrong in Samut Prakan Province...

In August 2025, we were pleased to activate a new C-FREE-2 site in Nakhon Si Thammarat Province in Southern Thailand . On 25-26 August 2025, a site initiation meeting was held to mark the beginning of this new site of the C-FREE-2 Research Project.   This expansion has been made possible through strong collaboration with local partners, including Chaloem Phra Kiat Hospital , Chaloem Phra Kiat District, Nakhon Si Thammarat Province, led by Site Principal Investigator Dr. Siriw

On 21 April 2025, Dreamlopments activated the protocol version 4.0 of the C-FREE-CSEA study at Mae Ramat site in Tak Province, in...

C-FREE-1 study was conducted from May 2019 to March 2023. In April 2023, C-FREE-2 was launched. The objectives and design remain comparable, but we now use a new combination of hepatitis C treatment called Sofosbuvir/Ravidasvir as the core treatment option.   However, as the Thai national treatment program no longer incorporates drug use as an exclusion criterion, in April 2025, the C-FREE-2 consortium launched protocol amendment 4.0 , adapting procedures to also study the ap

While the C-FREE project of hepatitis C treatment among high-risk communities is mainly implemented in partnership with civil society...

The C-FREE Study, Dreamlopments Foundation, organized the C-FREE Steering Committee and Partners Meeting on 2 July 2024, at the...

20 March 2024, Dr. Nicolas Durier, General Director of Dreamlopments (DLP) Foundation attended the signing ceremony of the “Collaborative...

March 19, 2024, Dr. Nicolas Durier, General Director of Dreamlopments (DLP) Foundation participated in commemorating the 25th anniversary...

On March 18, 2024, there was a site initiation meeting on the cooperation network in the C-FREE-CSEA at Pattani Hospital to start a new...

On 27 February 2024, Dr. Tanyaporn Wansom, Director of Research and Advocacy of the C-FREE project, Dreamlopments Foundation moderated a...